Hlavac et al. in 2014 assessed transcript levels of 10 CYP enzymes in 68 post treatment tumours of breast carcinoma patients and reported significantly higher intratumoural CYP2W1 in responders of neoadjuvant chemotherapy compared to non- responders [84]. This evidence concerns the gene CYP2W1 and breast carcinoma.